Matthias Aizenberg

Matthias Aizenberg

Healthcare Innovation Consultant
Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
Praxis Prices $575 Million Public Offering
Tech & Innovation Praxis Prices $575 Million Public Offering

Praxis Precision Medicines, a clinical-stage biopharmaceutical company dedicated to developing therapies for complex central nervous system disorders, has made a significant financial move by announcing the pricing of its underwritten public offering, which is expected to generate gross proceeds of

Study Finds Vitamin A Derivative Blocks Cancer Immunity
Research & Development Study Finds Vitamin A Derivative Blocks Cancer Immunity

New research from Princeton University’s Ludwig Institute for Cancer Research has untangled the complex and often harmful relationship between a vitamin A derivative and the body's ability to fight cancer, resolving a long-standing paradox about vitamin A's role in oncology and introducing a

Will Alumis' Pill Topple Psoriasis Market Leaders?
Research & Development Will Alumis' Pill Topple Psoriasis Market Leaders?

In the fast-evolving world of immunology, the race to develop a highly effective oral treatment for psoriasis has reached a fever pitch. With the recent success of Alumis's Phase 3 trials for envudeucitinib, the landscape is poised for a significant shift. We sat down with biopharma expert Ivan

Fujifilm Rebrands in a Major Life Sciences Push
Biotech & Bioprocessing Fujifilm Rebrands in a Major Life Sciences Push

A company once synonymous with capturing cherished family memories through photographic film is now engineering the very building blocks of life-saving medicines, marking one of the most significant corporate transformations in recent history. The name Fujifilm, long associated with vibrant color

Can Inhaled Nanotech Beat Resistant Melanoma?
Research & Development Can Inhaled Nanotech Beat Resistant Melanoma?

The advent of immunotherapy offered a powerful beacon of hope in the fight against advanced melanoma, yet for many patients and their families, that light has remained frustratingly out of reach. These revolutionary treatments, designed to unleash the body's own immune system against cancer, have

FDA 2025 Approvals Usher in a Disruptive Era for Medicine
Tech & Innovation FDA 2025 Approvals Usher in a Disruptive Era for Medicine

The 44 new drugs that gained approval from the FDA's Center for Drug Evaluation and Research in 2025 represented far more than a simple numerical milestone; they collectively heralded a fundamental paradigm shift in the landscape of therapeutic development. This pivotal year was defined not by the

Cancer's Achilles' Heel Found in Its Immune Shield
Research & Development Cancer's Achilles' Heel Found in Its Immune Shield

A groundbreaking study has unraveled a sophisticated deception used by aggressive breast cancer to build a fortress against the body's immune system, but in doing so, the cancer inadvertently leaves the key to its own destruction lying in plain sight. Research from scientists at Sun Yat-Sen

Biopharma Builds Resilient Networks for New Therapies
Biotech & Bioprocessing Biopharma Builds Resilient Networks for New Therapies

The successful journey of a life-saving gene therapy from a state-of-the-art laboratory to a patient's bedside now hinges less on its scientific brilliance and more on the sheer resilience of the global network tasked with its production. In a world defined by volatility, the biopharmaceutical

New Method Geometrically Maps Cell Fate Decisions
Research & Development New Method Geometrically Maps Cell Fate Decisions

The fundamental question of how a single cell gives rise to the incredible diversity of specialized cells that form a complex organism has long stood as a central pillar of biological inquiry. This process, known as cell differentiation, is the elegant choreography behind embryonic development,

AI Unlocks Precision Medicine for Multiple Myeloma
Research & Development AI Unlocks Precision Medicine for Multiple Myeloma

Beneath the lens of a standard microscope lies a hidden language of cancer, one that has remained largely untranslated by the human eye until now, holding the secrets to a patient's prognosis and optimal treatment path. For countless individuals diagnosed with multiple myeloma, a complex cancer of

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later